stockrowStryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Return on assets
Stryker Corporation's return on assets over the twelve months to 30 September 2026 was 7.68%, up 0.5 percentage points from fiscal 2025 (7.15%). Over the past ten years it has ranged from 4.79% (fiscal 2017) to 14.4% (fiscal 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 7.15% | (0.07) |
| FY2024 | 7.22% | (1.02) |
| FY2023 | 8.24% | 1.65 |
| FY2022 | 6.59% | 0.81 |
| FY2021 | 5.78% | 0.82 |
| FY2020 | 4.96% | (2.30) |
| FY2019 | 7.26% | (7.12) |
| FY2018 | 14.4% | 9.59 |
| FY2017 | 4.79% | (4.20) |
| FY2016 | 8.99% | 0.40 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.4% |
| BSX Boston Scientific Corporation compare | 7.94% |
| STE STERIS plc compare | 7.83% |
| SYK Stryker Corporation | 7.68% |
| EW Edwards Lifesciences Corporation compare | 7.45% |
| GEHC GE HealthCare Technologies Inc. compare | 5.78% |
| MDT Medtronic PLC compare | 5.68% |
| PHG Koninklijke Philips N.V. compare | 3.49% |
| ABT Abbott Laboratories compare | 0.00% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement